Curis News More News · Truist Financial Reaffirms Their Buy Rating on Curis (CRIS) · Buy Rating on Curis's Stock Amid Anticipated Data Updates and Promising Drug. Ratings · Revenues Working Against Curis, Inc.'s (NASDAQ:CRIS) Share Price Following 36% Dive · Analysts' Revenue Estimates For Curis, Inc. · Truist Financial. Get the latest Curis Inc (CRIS) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and. Stay up-to-date on Curis, Inc. Common Stock (CRIS) news with the latest updates, breaking headlines, news articles, and more from around the web at. Curis Inc (CRIS) has a Smart Score of 4 based on an analysis of 8 unique data sets, including Analyst Recommendations, Crowd Wisdom, and Hedge Fund Activity.
On average, Wall Street analysts predict that Curis's share price could reach $ by Aug 1, The average Curis stock price prediction forecasts a. Curis (NASDAQ:CRIS - Get Free Report) released its earnings results on Tuesday. The biotechnology company reported ($) earnings per share (EPS) for the. Curis (CRIS) Reports Q2 Loss, Tops Revenue Estimates. Curis (CRIS) delivered earnings and revenue surprises of % and %, respectively, for the quarter. Curis (CRIS) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might help the stock. View today's Curis Inc stock price and latest CRIS news and analysis. Create real-time notifications to follow any changes in the live stock price. View the latest Curis Inc. (CRIS) stock price, news, historical charts, analyst ratings and financial information from WSJ. Why Curis Stock Perked Up in August. The biotech's shares rode the wave of buyout speculation higher last month. George Budwell | Sep 8, Curis Inc. (CRIS). Curis, Inc NASDAQ: CRIS is a biotechnology company focused on the development of therapeutics for the treatment of cancer. Curis clinical. Get Curis Inc (CRIS.O) real-time stock quotes, news, price and financial information from Reuters to inform your trading and investments. The current price of CRIS is USD — it has decreased by −% in the past 24 hours. Watch Curis, Inc. stock price performance more closely on the chart. Curis trades higher as analysts reiterate their outlooks after the stock loses more than a third of its market value on disappointing trial results. CRIS.
Curis, Inc. (NASDAQ: CRIS) will release its first quarter financial results on May 7, , followed by a conference call. The company is focused on. CRIS | Complete Curis Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. In the current month, CRIS has received 10 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. CRIS average Analyst price target in the past 3 months is $ (NASDAQ:CRIS) Surges 54% Yet Its Low P/S Is No Reason For Excitement. Curis, Inc. (NASDAQ:CRIS) shareholders would be excited to see that the share price. Curis, Inc. is currently listed on NASDAQ under CRIS. One share of CRIS stock can currently be purchased for approximately $ Is It Time to Buy CRIS? Shares are down today. See Zacks' latest analysis. Plus, CRIS info will be updated daily in your free kursh-ms.ru Portfolio Tracker. Is It. Discover real-time Curis, Inc. Common Stock (CRIS) stock prices, quotes, historical data, news, and Insights for informed trading and investment decisions. CRIS Curis Inc. 13, $ $ (%). Today. Watchers, 13, Wk Low, $ Wk High, $ Market Cap, $M. Volume, 61, CRIS stock results show that Curis beat analyst estimates for earnings per share but missed on revenue for the first quarter of
In the last 3 years, CRIS stock traded as high as $ and as low as $ What are the top ETFs holding Curis? The top ETF exchange traded funds. Curis Inc CRIS:NASDAQ · Open · Day High · Day Low · Prev Close · 52 Week High · 52 Week High Date04/08/24 · 52 Week Low · 52 Week Low. Curis (NASDAQ:CRIS) Stock Quotes, Forecast and News Summary ; Day Range, $ - $ ; 52 Wk Range, - ; Market Cap, $M ; P/E Ratio, - ; Dividend. Curis News More News · Buy Rating on Curis's Stock Amid Anticipated Data Updates and Promising Drug Efficacy · Buy Rating Affirmed for Curis on Strong Financials. Curis Inc (CRIS) stock price, GURU trades, performance, financial stability, valuations, and filing info from GuruFocus.
Over the last year, Curis shares have traded in a share price range of $ to $ Curis currently has 5,, shares outstanding. The market.
Purchase Life Insurance For Someone Else | Average Cost Of New Furnace And Installation